Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PIK3CA | P42336 | 10/20 | 0.51 |
| ▸ | HASPIN | Q8TF76 | 5/20 | 0.39 |
| ▸ | MAP3K12 | Q12852 | 2/20 | 0.38 |
| ▸ | KCNH2 | Q12809 | 3/20 | 0.37 |
| ▸ | FLT3 | P36888 | 2/20 | 0.37 |
| ▸ | KIT | P10721 | 1/20 | 0.37 |
| ▸ | PIM1 | P11309 | 1/20 | 0.37 |
| ▸ | CDK7 | P50613 | 1/20 | 0.37 |
| ▸ | PIM3 | Q86V86 | 1/20 | 0.37 |
| ▸ | PIM2 | Q9P1W9 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL624438 | 0.91 | PIK3CA (0.50) | PIK3CAHASPINKCNH2FLT3KIT | |
| SCHEMBL624388 | 0.87 | PIK3CA (0.55) | PIK3CAHASPINMAP3K12KCNH2FLT3 | |
| SCHEMBL625459 | 0.85 | MAP3K12 (0.41) | PIK3CAMAP3K12 | |
| SCHEMBL626242 | 0.84 | PIK3CA (0.52) | PIK3CAHASPINMAP3K12KCNH2FLT3 | |
| SCHEMBL626107 | 0.81 | PIK3CA (0.48) | PIK3CAHASPIN | |
| SCHEMBL627019 | 0.81 | PIK3CA (0.47) | PIK3CAHASPINMAP3K12KCNH2FLT3 | |
| SCHEMBL625702 | 0.78 | PIK3CA (0.50) | PIK3CAHASPINMAP3K12KCNH2FLT3 | |
| SCHEMBL627410 | 0.78 | PIK3CA (0.57) | PIK3CAHASPINKCNH2FLT3KIT | |
| SCHEMBL625620 | 0.77 | PIK3CA (0.56) | PIK3CAHASPINKCNH2FLT3KIT | |
| SCHEMBL624439 | 0.77 | MAP3K12 (0.41) | PIK3CAMAP3K12 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2012020215-A1 | AMINO- IMIDAZOLOTHIADIAZOLES FOR USE AS PROTEIN OR LIPID KINASE INHIBITORS | CENTRO NACIONAL DE INVESTIGACIONES ONCOLÓGICAS (CNIO) (ES) | 2012-02-16 | — | — | WO | disclosed |